CHAMPIONS ONCOLOGY, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2024-04-30, per its 10-K filed 2024-07-19.
Discontinued › Expense Statement
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2024-07-19
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2021-04-30 was $3.00M.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $0.00.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $0.00.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CHAMPIONS ONCOLOGY, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $3.00M, a 88.89% decline from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|---|---|
| 2024-04-30 | $0.00 10-K · filed 2024-07-19 | |||
| 2023-04-30 | $0.00 10-K · filed 2024-07-19 | |||
| 2022-04-30 | $0.00 10-K · filed 2023-07-24 | |||
| 2021-04-30 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $3.00M 10-K · filed 2022-07-22 | $3.00K 10-K · filed 2021-07-26 | |
| 2021-01-31 | $3.00K 10-Q · filed 2021-03-15 | |||
| 2020-04-30 | $27.00M 10-K · filed 2021-07-26 | $27.00K 10-K · filed 2020-07-28 | ||
| 2019-04-30 | $0.00 10-K · filed 2020-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |